The effects of inflammatory factors or chronic inflammatory responses on metabolic-related diseases such as NAFLD are associated with sustained activation of the STAT3 signaling pathway. This evidence concerns the gene STAT3 and metabolic dysfunction-associated steatotic liver disease.